FDA
Carbidopa; Leodopa
The FDA lists this product in 8 strengths and forms.
Composition
- Active ingredients
- CARBIDOPA 245MG; LEODOPA
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARBIDOPA 195MG; LEODOPA · Capsule, extended releaseANDA210911-009 · Tentative approval
- CARBIDOPA 61.25MG; LEODOPA · Capsule, extended releaseANDA210911-007 · Tentative approval
- CARBIDOPA 95MG; LEODOPA · Capsule, extended releaseANDA210911-005 · Tentative approval
- CARBIDOPA 145MG; LEODOPA · Capsule, extended releaseANDA210911-003 · Tentative approval
- CARBIDOPA 48.75MG; LEODOPA · Capsule, extended releaseANDA210911-008 · Tentative approval
- CARBIDOPA 245MG; LEODOPA · Capsule, extended releaseThis page
- CARBIDOPA 23.75MG; LEODOPA · Capsule, extended releaseANDA210911-004 · Tentative approval
- CARBIDOPA 36.25MG; LEODOPA · Capsule, extended releaseANDA210911-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA210911.
At a glance
- Brand name
- Carbidopa; Leodopa
- Active substance
- carbidopa
- Dosage form
- Capsule, extended release
- Applicant
- Zydus Pharms USA Inc
- Status
- Tentative approval
- FDA approval
- 8 Aug 2025
- Application
- ANDA210911-006